Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

FDA approves removal of boxed warning from label for osteoporosis drug Tymlos

By Brian Buntz | January 3, 2022

RadiusRadius Health (NASDAQ:RDUS) has announced that the FDA has approved removing a boxed warning from the label of Tymlos, an osteoporosis drug.

The warning had described a risk of osteosarcoma, a type of bone cancer.

The agency reviewed long-term post-marketing data related to the drug and the broader class of related parathyroid hormone (PTH) drugs.

“This is an important update to the Tymlos label,” said Dr. Bruce Mitlak, the chief medical officer of Radius, in a statement. “Achieving this result was made possible by FDA analysis of a significant amount of data that had been generated over many years.”

The FDA first approved Tymlos (abaloparatide) as an osteoporosis treatment in individuals with a high fracture risk.

RDUS shares ticked up 2% on December 24 to $7.14.

 


Filed Under: clinical trials, Drug Discovery
Tagged With: abaloparatide, osteoporosis, osteosarcoma, parathyroid hormone, Tymlos
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

EpicentRx
A next-gen vaccine that could help end COVID-19 whack-a-mole 
Diversity
Making diversity in clinical research more than a talking point
psychedelic medicine discussed at SXSW
5 headwinds and 5 tailwinds for psychedelic medicine
lab microscope
Accelerating R&D with FAIR data

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50